Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2005
08/11/2005US20050175579 linear, cross-linked or high molecular weight acrylic acid-based polymers: polyacrylic acid cross-linked with allyl sucrose, allylpentaerythritol, acrylic or methacrylic acid or both modified with c10-c30 acrylate, crosslinked by allyl ethers as modulator of the enzyme responsible for inflammation
08/11/2005US20050175565 Use of taurine for the treatment of alopecia
08/11/2005US20050175559 Applying to the skin a topical preperation containing idebenone salt or ester; melanins
08/11/2005US20050175555 2,4,6,8,10,12,14-hexadecaheptaenol in cyclodextrins; antitumor , antiinflammatory, antiaging, antiprolifrative agent, antioxident; activation of free radical production, cardiovascular disorders, atherosclerosis; cosmetic and pharmaceutical use
08/11/2005US20050175554 as a UV filter in cosmetic preparation; skin and hair; R3-substituted 2-(4-aminophenyl)-benzothiazole by alkylation with the appropriate haloalkanes/haloaralkanes using a base
08/11/2005US20050175549 Novel combination of anticholinergic and ss mimetics for the treatment of respiratory diseases
08/11/2005US20050175548 a mixture of glycopyrrolate and budesonide, fluticasone, ciclesonide, mometasone, flunisolide, beclometason or loteprednol, used for treating respiratory system diosders and allergies; side effect reduction
08/11/2005US20050175547 Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
08/11/2005US20050175545 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
08/11/2005US20050175544 Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
08/11/2005US20050175539 Compositions inhibiting rejection in organ transplantation and method of using the same
08/11/2005DE202005004661U1 Composition containing tiotropium, useful for treatment of respiratory diseases by inhalation, comprises a dry powder filled directly into a sealed container
08/11/2005DE102004032781A1 New lipid-modified bis-phosphonic acid derivatives, useful e.g. for transporting therapeutic or diagnostic agents, with affinity for bone, also as corrosion inhibitors
08/11/2005DE102004028415B4 Dermales oder transdermales therapeutisches System enthaltend eine Abdeckfolie mit Barrierewirkung The dermal or transdermal therapeutic system comprising a cover sheet with barrier effect
08/11/2005DE102004003428A1 Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel New long-acting beta-2-agonists, and their use as medicaments
08/11/2005DE102004002351A1 New RNA aptamers specific for lipopolysaccharide-binding protein, useful for diagnosis and treatment of sepsis, inhibit the lipopolysaccharide-induced signaling cascade
08/11/2005DE102004002001A1 Mittel zur Behandlung von entzündlichen Erkrankungen Agents for the treatment of inflammatory diseases
08/11/2005DE102004001607A1 Neue Arzneimittelkombinationen auf der Basis von Scopin- oder Tropensäureestern mit EGFR-Kinase-Hemmern New drug combinations on the basis of scopine or tropical acid esters with EGFR kinase inhibitors
08/11/2005CA2774961A1 Oral care compositions comprising increased bioavailable levels of quaternary ammonium antimicrobials
08/11/2005CA2609888A1 Polyphenols as an intravesical agent for the prevention of transitional cell tumor implantation
08/11/2005CA2555763A1 Therapeutic agent for vasospasm accompanying bypass operation
08/11/2005CA2555367A1 Apoe genetic markers associated with age of onset of alzheimer's disease
08/11/2005CA2554959A1 Combination of a nmda receptor antagonist and a mao-inhibitor or a gadpf-inhibitor for the treatment of central nervous system-related conditions
08/11/2005CA2554925A1 2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
08/11/2005CA2554911A1 Urea derivatives
08/11/2005CA2554886A1 Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
08/11/2005CA2554825A1 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone
08/11/2005CA2554755A1 Functionalized colloidal metal compositions and methods
08/11/2005CA2554749A1 P2x receptor inhibitor
08/11/2005CA2554735A1 Therapeutic and carrier molecules
08/11/2005CA2554733A1 Method for producing sorbicillactone a
08/11/2005CA2554600A1 Enhancement of ampakine-induced facilitation of synaptic responses by cholinesterase inhibitors
08/11/2005CA2554527A1 Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
08/11/2005CA2554525A1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
08/11/2005CA2554524A1 Indazole derivatives as inhibitors of hormone-sensitive lipases
08/11/2005CA2554522A1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
08/11/2005CA2554489A1 Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
08/11/2005CA2554455A1 Anorectic
08/11/2005CA2554387A1 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
08/11/2005CA2554246A1 Nanosuspensions of anti-retroviral agents for increased central nervous system delivery
08/11/2005CA2554245A1 Novel hiv protease inhibitors
08/11/2005CA2554205A1 Novel inhibitors of chymase
08/11/2005CA2554201A1 Compositions and use of tyrosine kinase inhibitors to treat pathogenic infection
08/11/2005CA2554185A1 Neuroprotective complex for treatment of cerebral ischemia and injury
08/11/2005CA2554182A1 Compositions enriched in phenolic compounds and methods for producing the same
08/11/2005CA2554163A1 Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof
08/11/2005CA2554071A1 A-type procyanidins useful in the treatment of nitric oxide mediated disorders
08/11/2005CA2554064A1 Treatment methods
08/11/2005CA2554025A1 Enhancement of anti-androgenic activity by a combination of inhibitors targeting different steps of a steroid-dependent gene activation pathway and uses thereof
08/11/2005CA2553968A1 Vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain
08/11/2005CA2553931A1 Erythrocyte function modifying substance
08/11/2005CA2553866A1 Treatment of degenerative cartilage conditions in a mammal with glycosi dase inhibitors
08/11/2005CA2553814A1 Treating a viral disorder
08/11/2005CA2553805A1 Improved inactivated feline calicivirus vaccines
08/11/2005CA2553775A1 Compositions and methods of treatment for inflammatory diseases
08/11/2005CA2553674A1 Growth factor-binding compounds and methods of use
08/11/2005CA2553670A1 Anti-viral therapeutics
08/11/2005CA2553455A1 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis
08/11/2005CA2553450A1 6,11-3c-bicyclic 8a-azalide derivatives
08/11/2005CA2553433A1 Quinoline quinazoline pyridine and pyrimidine compounds and their use in the treatment of inflammation angiogenesis and cancer
08/11/2005CA2553390A1 Vaginal compositions for treating infections
08/11/2005CA2553387A1 Piperidinyl prostaglandin e analogs
08/11/2005CA2553318A1 Pyranone derivatives useful for treating cancer
08/11/2005CA2553104A1 Antisense oligomers and methods for inducing immune tolerance and immunosuppression
08/11/2005CA2553089A1 Novel piperidines as chemokine modulators (ccr)
08/11/2005CA2553084A1 Novel benzofuran derivative, medicinal composition containing the same, and uses of these
08/11/2005CA2552918A1 Gossypol derivatives, production method thereof and uses of same
08/11/2005CA2552558A1 Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole
08/11/2005CA2552391A1 Oligonucleotide and the use thereof for modulating an isoform c beta-1 protein-kinase in the form of a skin depigmentation agent
08/11/2005CA2552317A1 Hcv ns-3 serine protease inhibitors
08/11/2005CA2551882A1 Reelin deficiency or dysfunction and methods related thereto
08/11/2005CA2551778A1 Imidazo[1,2-c]pyrimidinylacetic acid derivatives
08/11/2005CA2551142A1 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics
08/11/2005CA2550576A1 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same
08/11/2005CA2549029A1 Compositions for treatment or prevention of metabolic syndrome
08/11/2005CA2545501A1 Methods and compositions for the treatment of skin changes associated with aging and environmental damage
08/11/2005CA2540308A1 Drug coating providing high drug loading and methods for providing the same
08/10/2005EP1561815A2 Tissue-specific and target rna-specific ribozymes
08/10/2005EP1561760A2 Low molecular weight heparin salt with thriethanolamine
08/10/2005EP1561753A2 Benzo[b]chromenonapthyridin-7-one and pyrano[2',3':7,8]quino[2,3-b]Quinoxalin-7-one derivatives, process of synthesis, pharmaceutical compositions and their antitumoral properties for the treatment of cancer
08/10/2005EP1561752A1 Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
08/10/2005EP1561751A1 Fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
08/10/2005EP1561749A1 TNF-Alpha production inhibitors for the treatment of autoimmune diseases
08/10/2005EP1561744A2 Amine derivatives, process for producing the same and their use as antimycotic agent
08/10/2005EP1561472A1 Solid preparation
08/10/2005EP1561471A1 Cell growth regulator
08/10/2005EP1561467A1 Composition for restoring damaged skin
08/10/2005EP1561466A2 Boronic acid salts and use thereof in the preparation of medicaments for treating thrombosis
08/10/2005EP1561465A2 Methods of use of fluoroquinolone compounds against bacteria
08/10/2005EP1561464A2 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
08/10/2005EP1561463A2 Benzamidoxime prodrugs as antipneumocystic agents
08/10/2005EP1561462A2 Anti arrhytmic composition and methods of treatment
08/10/2005EP1561461A2 Adhesive mixture for transdermal delivery of highly plasticizing drugs
08/10/2005EP1561459A1 Pharmaceutical hard capsule containing inorganic substance
08/10/2005EP1561458A1 Rapidly disintegrable solid preparation
08/10/2005EP1561425A1 Indocyanine dyes
08/10/2005EP1560925A2 Inhibitors of inflammatory gene activity and cholesterol biosynthesis
08/10/2005EP1560856A1 Isolating chondroitin sulfate
08/10/2005EP1560855A1 Polysaccharide of echinacea angustifolia
08/10/2005EP1560834A1 New tricyclic derivatives as ltd4 antagonists
1 ... 4584 4585 4586 4587 4588 4589 4590 4591 4592 4593 4594 4595 4596 4597 4598 4599 4600 4601 4602 4603 4604 ... 7860